Biotest
David Christopher Graves has extensive work experience in building services and utilities engineering in the pharmaceutical industry. David Christopher was the Head of Department for building services and utilities and engineering at Biotest AG from 2010 to the present, where they oversaw the utilities and media supply systems for pharmaceutical production. Prior to that, they served as the Group Manager for building services engineering at NNE Pharmaplan from 2005 to 2009.
David Christopher Graves attended the University of Applied Sciences Gießen-Friedberg in Germany from 1987 to 1991. David Christopher obtained a degree in Energie- und Umwelttechnik, earning the title of Diplom-Ingenieur.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.